US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 0.4611
  • -0.0019-0.41%
Close Nov 29 13:00 ET
  • 0.4631
  • +0.0020+0.43%
Post 17:01 ET
3.73MMarket Cap-63P/E (TTM)

Virpax Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-68.53%1.92M
6.76%3.46M
100.02%3.3M
-22.46%16.94M
91.29%5.93M
-20.74%6.12M
-45.13%3.24M
-67.78%1.65M
81.66%21.85M
-24.74%3.1M
Selling and administrative expenses
-83.09%780.96K
-22.91%1.5M
306.59%1.69M
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-76.69%415.45K
54.21%11.08M
-26.47%1.74M
-General and administrative expense
-83.09%780.96K
-22.91%1.5M
306.59%1.69M
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-76.69%415.45K
54.21%11.08M
-26.47%1.74M
Research and development costs
-23.55%1.14M
51.54%1.96M
30.56%1.61M
-52.45%5.12M
-19.30%1.1M
-46.68%1.5M
-60.39%1.29M
-63.02%1.24M
122.41%10.76M
-22.39%1.36M
Operating profit
68.53%-1.92M
-6.76%-3.46M
-100.02%-3.3M
22.46%-16.94M
-91.29%-5.93M
20.74%-6.12M
45.13%-3.24M
67.78%-1.65M
-81.66%-21.85M
24.74%-3.1M
Net non-operating interest income expense
-92.75K
-11K
0
0
Non-operating interest expense
--92.75K
--11K
----
----
----
--0
--0
----
----
----
Other net income (expense)
-91.18%10.65K
-84.91%19.13K
-37.15%82.03K
800.29%1.75M
1,093.69%1.37M
64.69%120.64K
554.07%126.72K
1,090.15%130.53K
212.26%194.41K
3,526.81%114.97K
Special income (charges)
----
----
----
--1.25M
----
----
----
----
----
----
-Less:Other special charges
----
----
----
---1.25M
----
----
----
----
----
----
Other non- operating income (expenses)
-91.18%10.65K
-84.91%19.13K
-37.15%82.03K
157.33%500.28K
6.45%122.39K
64.69%120.64K
554.07%126.72K
1,090.15%130.53K
212.26%194.41K
3,526.81%114.97K
Income before tax
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
Income tax
0
0
0
0
0
Net income
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
Net income continuous Operations
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
Minority interest income
Net income attributable to the parent company
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
Basic earnings per share
91.60%-0.43
34.21%-1.75
-111.54%-2.75
29.85%-12.97
-50.58%-3.9
21.23%-5.12
46.80%-2.66
70.45%-1.3
-2.15%-18.49
26.31%-2.59
Diluted earnings per share
91.60%-0.43
34.21%-1.75
-111.54%-2.75
29.85%-12.97
-50.58%-3.9
21.23%-5.12
46.80%-2.66
70.45%-1.3
-2.15%-18.49
26.31%-2.59
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -68.53%1.92M6.76%3.46M100.02%3.3M-22.46%16.94M91.29%5.93M-20.74%6.12M-45.13%3.24M-67.78%1.65M81.66%21.85M-24.74%3.1M
Selling and administrative expenses -83.09%780.96K-22.91%1.5M306.59%1.69M6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-76.69%415.45K54.21%11.08M-26.47%1.74M
-General and administrative expense -83.09%780.96K-22.91%1.5M306.59%1.69M6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-76.69%415.45K54.21%11.08M-26.47%1.74M
Research and development costs -23.55%1.14M51.54%1.96M30.56%1.61M-52.45%5.12M-19.30%1.1M-46.68%1.5M-60.39%1.29M-63.02%1.24M122.41%10.76M-22.39%1.36M
Operating profit 68.53%-1.92M-6.76%-3.46M-100.02%-3.3M22.46%-16.94M-91.29%-5.93M20.74%-6.12M45.13%-3.24M67.78%-1.65M-81.66%-21.85M24.74%-3.1M
Net non-operating interest income expense -92.75K-11K00
Non-operating interest expense --92.75K--11K--------------0--0------------
Other net income (expense) -91.18%10.65K-84.91%19.13K-37.15%82.03K800.29%1.75M1,093.69%1.37M64.69%120.64K554.07%126.72K1,090.15%130.53K212.26%194.41K3,526.81%114.97K
Special income (charges) --------------1.25M------------------------
-Less:Other special charges ---------------1.25M------------------------
Other non- operating income (expenses) -91.18%10.65K-84.91%19.13K-37.15%82.03K157.33%500.28K6.45%122.39K64.69%120.64K554.07%126.72K1,090.15%130.53K212.26%194.41K3,526.81%114.97K
Income before tax 66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M
Income tax 00000
Net income 66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M
Net income continuous Operations 66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M
Minority interest income
Net income attributable to the parent company 66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M
Basic earnings per share 91.60%-0.4334.21%-1.75-111.54%-2.7529.85%-12.97-50.58%-3.921.23%-5.1246.80%-2.6670.45%-1.3-2.15%-18.4926.31%-2.59
Diluted earnings per share 91.60%-0.4334.21%-1.75-111.54%-2.7529.85%-12.97-50.58%-3.921.23%-5.1246.80%-2.6670.45%-1.3-2.15%-18.4926.31%-2.59
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data